Studies carried out with animal models suggested that hyperactivation of IGF1R/mTOR signaling pathway may promote hepatocarcinogenesis, while blocking this pathway showed promising reduction of HCC tumor growth [9, 10]. This evidence concerns the gene MTOR and hepatocellular carcinoma.